01 1Bortezomib 3.5mg/vial
02 1Loncastuximab tesirine
03 1Patritumab deruxtecan
04 2Pemetrexed disodium heptahydrate
05 1sacituzumab govitecan
01 6BSP Pharmaceuticals S.p.A.
01 6Italy
NDC Package Code : 43624-024
Start Marketing Date : 2003-05-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (3.5mg/3.5mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-004
Start Marketing Date : 2021-05-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (10mg/2.2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-021
Start Marketing Date : 2024-01-04
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-006
Start Marketing Date : 2004-02-04
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER, FOR SOLUTION (500mg/20mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-005
Start Marketing Date : 2008-01-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER, FOR SOLUTION (100mg/4.2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43624-008
Start Marketing Date : 2020-04-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (180mg/180mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
Bsp Pharmaceuticals is a supplier offers 5 products (APIs, Excipients or Intermediates).
Find Bortezomib bulk offered by Bsp Pharmaceuticals
Find Loncastuximab Tesirine bulk offered by Bsp Pharmaceuticals
Find Pemetrexed Disodium bulk offered by Bsp Pharmaceuticals
Find Sacituzumab Govitecan bulk offered by Bsp Pharmaceuticals
Find PATRITUMAB DERUXTECAN bulk offered by Bsp Pharmaceuticals
